In the face of increasing R&D costs and an escalating number of potential biological targets and chemical hits from high throughput screening, pharmaceutical and biotechnology companies require, more than ever, a trusted strategic partner to relieve the bottlenecks in drug discovery.
Argenta sets new standards. Our management and scientists draw on a wealth of experience obtained at major pharmaceutical companies including Roche, Aventis, GlaxoSmithKline and Celltech Chiroscience. We have a flexible and dynamic approach to projects and draw on our multidisciplinary teams to deliver world class hit-to-lead and lead optimisation services, and to accelerate our partners’ drug discovery programmes.
The company does not perform any animal experiments.